Lipid nanoparticles of zaleplon for improved oral delivery by Box–Behnken design: optimization, in vitro and in vivo evaluation

Narendar Dudhipala, Karthik Yadav Janga
  • Drug Development and Industrial Pharmacy, March 2017, Taylor & Francis
  • DOI: 10.1080/03639045.2017.1304957

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1080/03639045.2017.1304957

The following have contributed to this page: Narendar Dudhipala

In partnership with: